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1. Introduction  
The Rho GTPases is a subfamily of molecular switches that cycle between an inactive 
GDP-bound state and an active GTP-bound state within the Ras superfamily. In the past, 
members of the Rho subfamily were mainly thought to be involved in the regulation of 
cytoskeletal organization in response to extracellular growth factors. However, a number 
of studies over the past few years have revealed that the Rho GTPases play crucial roles in 
a wide spectrum of cellular functions related to cell adhesion to the extracellular matrix, 
cell morphology, cell cycle progression, malignant transformation, invasion and 
metastasis. Alterations of the expression levels to Rho GTPases have been detected in 
many types of human tumors and, in some cases, up-regulation and/or overexpression of 
Rho protein correlates with poor prognosis. This article reviews the evidence of aberrant 
Rho signaling and the cellular effects elicited by Rho GTPases signaling in human breast 
tumors. 
2. Categorization 
Rho GTPases belong to the Ras superfamily of low molecular mass (~21 kDa) proteins that 
are widely expressed in mammalian cells (DerMardirossian and Bokoch 2001). In mammals, 
the Rho family of GTPases contains 22 members which can be classified into six groups: Rho 
(RhoA, RhoB, RhoC), Rac (Rac1, Rac2, Rac3, RhoG), Cdc42 (Cdc42, TC10, TCL, Chp, Wrch-
1), Rnd (Rnd1, Rnd2, Rnd3/RhoE), RhoBTB (RhoBTB1, RhoBTB2) and Miro (Miro-1, Miro-2) 
(Wennerberg and Der 2004). RhoD, Rif and RhoH/TTF have not been grouped yet. RhoA, 
Rac1 and Cdc42 are the best-characterized family members of Rho family GTPases. Each 
controls the formation of a distinct cytoskeletal element in mammalian cells. Activation of 
Rac induces Actin polymerization to form lamellipodia (Ridley, Paterson et al. 1992), 
whereas activation of CDC42 stimulates the polymerization of actin to filopodia or 
microspikes (Nobes and Hall 1995). In contrast, Rho regulates bundling of actin filaments 
into stress fibers and the formation of focal adhesion complexes (Keely, Westwick et al. 
1997). 
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3. Regulators and effectors in Rho GTPases signaling 
3.1 Regulators of the Rho GTPases  
Like all members of the Ras superfamily, the activity of the Rho GTPases is tightly 
controlled by the ratio of their GTP/GDP-bound forms in the cell (Fig. 1)(Scheffzek and 
Ahmadian 2005).  
 
 
Fig. 1. Regulation of Rho family proteins. 
The cycle of activation/inactivation of Rho family GTPases is under the regulation of three 
distinct families of proteins: GEFs, guanine nucleotide exchange factors catalyze nucleotide 
exchange when activated by upstream signals; GAPs, GTPase-activating proteins promote 
the GTP hydrolisis; GDIs, guanine nucleotide dissociation inhibitors block both nucleotide 
hydrolisis and exchange and participate in Rho GTPase movement between cytosol and 
membranes. 
Rho-specific guanine nucleotide exchange factors (RhoGEFs) activate Rho proteins by 
facilitating the exchange of GDP for GTP. Rho GTPase activating proteins (RhoGAPs) 
stimulate the intrinsic rate of hydrolysis of Rho proteins, thus converting them into their 
inactive state. While Rho-specific guanine nucleotide dissociation inhibitors (RhoGDIs) 
compete with RhoGEFs for binding to GDP-bound Rho proteins, and sequester Rho in the 
inactive state (Olofsson 1999). 
3.1.1 GEFs 
GEFs for Rho GTPases belong to a rapidly growing family of proteins that share common 
minimal functional units, including a Db1-homolog (DH) domain followed by a pleckstrin 
homology (PH) domain (Cerione and Zheng 1996). The DH domain is the catalytic site 
required for GDP-GTP exchange, whereas the PH domain contributes to protein-protein, 
protein-cytoskeleton, and protein-lipid interactions that help regulate the intracellular 
localization of GEFs as well as their catalytic activity. Db1 oncogene product is the prototype 
for the DH domain, and was originally discovered because of its ability to induce focus 
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formation and tumorigesis when expressed in NIH-3T3 cells (Eva and Aaronson 1985). It 
has 29% sequence identity with the Saccharomyces cerevisiae cell division protein Cdc24, 
which is found upstream of the yeast small GTP-binding protein Cdc42 in the bud assembly 
pathway (Ron, Zannini et al. 1991). This was the first clue that DB1 functions as a GEF. 
Biochemical study has confirmed that Db1 is able to release GDP from the human homolog 
of Cdc42 in vitro. Further study suggested that the DH domain is essential and sufficient for 
the catalytic activity and that this domain was also necessary to induce oncogenicity (Zheng, 
Zangrilli et al. 1996). 
After the discovery of Dbl, a number of mammalian proteins containing DH and PH domain 
have been studied (Cerione and Zheng 1996). Many of these have been identified as 
oncogenes in transfection assays. Tiam, however, was first identified as an invasion-
inducing gene using proviral tagging and in vitro selection for invasiveness (Habets, 
Scholtes et al. 1994). Two other members of the DH/PH-containing protein family, Fgd1 and 
Vav, have been shown to be essential for normal embryonic development (Pasteris, Cadle et 
al. 1994; Tarakhovsky, Turner et al. 1995). Moreover, some members of the DH protein 
family (such as Dbl) have been shown to exhibit exchange activity in vitro for a broad range 
of Rho-like GTPases, whereas others appear to be more specific. For example, Lbc and 
oncoproteins Lfc and Lsc, are specific for Rho, whereas Fgd1 is specific for Cdc42 (Glaven, 
Whitehead et al. 1996). Although Vav was originally identified as an activator of Ras 
(Gulbins, Coggeshall et al. 1993), it has been demonstrated more recently to function as a 
GEF for members of the Rho family (Crespo, Schuebel et al. 1997; Han, Das et al. 1997). 
3.1.2 GAPs 
The first GAP protein specific for the Rho family GTPases was purified from cell extracts 
using recombinant Rho. This protein, designated p50Rho-GAP, was shown to have GAP 
activity toward Rho, Cdc42 and Rac in vitro (Hall 1990; Lancaster, Taylor-Harris et al. 1994). 
Since then, a growing number of proteins that present GAP activity for Rho GTPases have 
been identified in mammalian cells, all of which share a related GAP domain that spans 140 
amino acids without significant resemblance to Ras GAP. In addition to accelerating the 
hydrolysis of GTP, Rho GAPs also mediate other downstream functions of Rho proteins in 
mammalian systems. For example, it has been reported that the p190GAP plays a role in 
cytoskeletal rearrangement (Chang, Gill et al. 1995).  
3.1.3 GDIs 
The ubiquitously expressed protein Rho GDI was the first GDI identified for the members of 
the Rho family. It was isolated as a cytosolic protein that preferentially associated with the 
GDP-bound form of RhoA and RhoB and thereby inhibited the dissociation of GDP 
(Fukumoto, Kaibuchi et al. 1990; Ueda, Kikuchi et al. 1990). Rho GDI was found to be active 
on Cdc42 and Rac as well (Abo, Pick et al. 1991; Leonard, Hart et al. 1992). Further studies 
demonstrated that Rho GDI also associated weakly with the GTP-bound form of Rho, Rac, 
and Cdc42 (Hart, Maru et al. 1992; Chuang, Xu et al. 1993), leading to an inhibition of the 
intrinsic and GAP-stimulated GTPase activity of the Rho GTPases. Therefore, Rho GDI 
appears to be a molecule capable of blocking both the GDP/GTP exchange step and the GTP 
hydrolytic step. It was also reported that the Rho GDIs play a crucial role in the 
translocation of the Rho GTPases between membranes and the cytoplasm. In resting cells, 
the Rho proteins are found in the cytosol as a complex with Rho GDIs, which inhibit their 
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GTP/GDP exchange ratio, but are released from the GDI and translocated to the membranes 
during the course of cell activation (Takai, Sasaki et al. 1995).  
3.2 Effectors of the Rho GTPases 
The Rho GTPases have been implicated in a wide varity of cellular processes, including 
cytoskeletal organization, cell adhesion to the substratum, cell polarity, and 
transcriptional activation. Several lines of evidence indicate that Rho GTPases link plasma 
membrane receptors to the assembly and organization of the actin cytoskeleton. Rho 
GTPases control individual aspects of the actin cytoskeleton through distinct effector 
proteins. In fact, over 60 targets of the three common Rho GTPases (Rho, Rac, Cdc42) have 
been found (Fig. 2).  
 
 
Fig. 2. Regulators and mammalian targets of the Rho family GTPases. 
Transmembrane receptors activate Rho GTPases through GEFs such as Tiam-1 or adaptor 
proteins. Activated Rho GTPases bind to and activate protein kinases, including these of the 
MRCK, PAK and ROCK families. The effector proteins then interact with several proteins 
with distinct effects on the actin cytoskeleton and cellular morphology. See text for details. 
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3.2.1 Rho signaling 
Rho was originally studied for its role in regulate the formation of stress fibers and focal 
adhesion (FA) complexes (Nobes and Hall 1995) which precursors actomyosin assembly and 
contractile potential, both of which are required for the cellular movement. Rho is also 
involved in cell-cell adhesion. In particular, inactivation of RhoA by C3 transferase disrupts 
the organization of actin filaments at cell-cell contact, leading to the inhibition of the proper 
formation of both adherens junctions (AJs) and tight junctions (TJs) (Braga, Machesky et al. 
1997; Takaishi, Sasaki et al. 1997). For example, in normal mammary epithelial cells, MCF10 
cells, E-cadherin cytoskeletal links in AJs was disrupted by C3 transferase. In addition, 
inhibition of Rho blocks the formation of new AJs in MCF10 cells (Zhong, Kinch et al. 1997). 
It has been suggested that the function of Rho can be either promoted or antagonized by Rac 
and Cdc42, depending on different variables, such as cellular context, stimulus, and 
extracellular matrix (ECM) (Zhang, Nie et al. ; Narumiya and Morii 1993; Nobes and Hall 
1995). In Swiss 3T3 fibroblasts, the Rho GTPases have been placed in a hierarchical order 
where Cdc42 activates Rac, and Rac activates Rho (Nobes and Hall 1995); however, in N1E-
115 neuroblastoma and Madine-Darby canine kidney (MDCK) cells, constitutively activated 
Rac down-regulates Rho (Leeuwen, Kain et al. 1997; Michiels and Collard 1999). 
Rho is widely studied for its involvement in the acquisition of migratory, invasive, and 
metastatic phenotypes. Expression of a dominant negative form of RhoA led to the 
attenuation of membrane ruffling, lamellipodia formation and migration (O'Connor, 
Nguyen et al. 2000). In addition, RhoA localization to lamellipodia was blocked by 
inhibiting phosphodiesterase activity while enhanced by inhibiting cAMP-dependent 
protein kinase activity (O'Connor, Nguyen et al. 2000). Furthermore, activation of Rho either 
by LPA treatment or by stimulating the actomyosin system has been associated with the 
migratory ability of tumor cells. For example, in an experimental metastasis model, NIH3T3 
fibroblasts expressing a constitutively active form of RhoA were injected into the tail vein of 
nude mice and formed increased number metastasis nodules in the lung (del Peso, 
Hernandez-Alcoceba et al. 1997). Moreover, in the absence of serum, activated RhoA is 
capable of promoting invasion of cultured rat MM1 hepatoma cells through a mesothelial 
cell monolayer (Yoshioka, Matsumura et al. 1998). Although these are not oncogenes by 
themselves, RhoA and RhoC are frequently found to be overexpressed in clinical cancers 
(Sahai and Marshall 2002), and RhoC has been repeatedly associated with metastasis. For 
example, the expression of RhoA, RhoB and RhoC in 33 pancreatic ductal adnocarcinoma 
cases were examined in a study (Suwa, Ohshio et al. 1998), it was found that the expression 
level of RhoC was higher in tumors than in non-malignant tissues, higher in metastatic 
lesions than in primary tumors, and correlated with perineural invasion and lymph node 
metastasis as well as poorer prognosis. Although early studies showed that RhoB has a 
positive role in cell growth, more recent studies suggested that RhoB is down-regulated in 
human tumors, and its expression inversely correlates with tumor aggressiveness. For 
example, RhoB protein is found expressed in normal lung tissue and is lost progressively 
throughout lung cancer progression (Mazieres, Antonia et al. 2004). In line with this, higher 
expression of RhoB is associated with favorable prognosis in bladder cancer (Kamai, Tsujii 
et al. 2003). It has been suggested that RhoB can act as a tumor suppressor, since it is 
activated in response to several stress stimuli, such as DNA damage and hypoxia, inhibits 
tumor growth, cell migration, and invasion, and has proapoptotic functions in cells (Huang 
and Prendergast 2006).  
www.intechopen.com
 
Breast Cancer – Focusing Tumor Microenvironment, Stem Cells and Metastasis 564 
3.2.2 Effectors of Rho 
There are two major effectors that are downstream of Rho: Rho associated coiled-coil 
forming kinase (ROCK/Rho kinase/ROK) (Leung, Manser et al. 1995; Ishizaki, Maekawa et 
al. 1996) and mammalian homolog of Drosophila diaphanous (mDia) (Watanabe, Madaule 
et al. 1997; Wasserman 1998). While mDia is a formin molecule that can catalyze actin 
nucleation, polymerization,and produce long, straight actin filaments (Goode and Eck 2007), 
ROCK is a serine/threonine kinase that phosphorylates a number of substrates (Riento and 
Ridley 2003). The actions of ROCK and mDia on actin and myosin are believed to work 
together to induce actomyosin bundles in cells. Expression of an active form of mDia 
induces stress fibers in cultured cells, and treatment of these cells with a specific ROCK 
inhibitor, Y-27632 (Narumiya, Ishizaki et al. 2000), causes dissolution of the bundles, leaving 
the cells with diffusely distributed actin filaments (Watanabe, Kato et al. 1999). It has also 
been reported that ROCK and mDia are required in contractile ring formations (Kosako, 
Yoshida et al. 2000; Watanabe, Ando et al. 2008).  
At least six substrates of ROCK are known to play roles in actin cytoskeletal reorganization, 
including myosin light chain (MLC), myosin-binding subunit of MLC phosphatase, LIM-
kinase, adducin, ezrin/radixin/moesin (ERM) family of proteins, and Na+/H+ exchange 
protein (NHE1). Among the six substrates, MLC-phosphatase, MLC, and LIM-kinase, are 
the three best studied ROCK effectors and have been found to play important roles in 
driving ROCK’s physiological function on the actin cytoskeleton. ROCK inactivates myosin-
binding subunit of MLC-phosphatase by phosphorylation (Kimura, Ito et al. 1996; Uehata, 
Ishizaki et al. 1997). ROCK is also able to phosphorylate myosin light chain directly 
(Maekawa, Ishizaki et al. 1999). These two actions of ROCK increase the myosin light chain 
phosphorylation, stimulate cross-linking of actin by myosin and enhance actomyosin 
contractility. ROCK also phosphorylates and activates LIM-kinase, which in turn 
phosphorylates and inactivates actin-depolymerizing and severing factor, cofilin (Amano, 
Ito et al. 1996). The later action of ROCK results in stabilization of existing actin filaments 
and increase in their content. 
The ROCK effectors adducin and the ERM family of proteins regulate actin cytoskeleton 
in a more direct way. ROCK has been shown to phosphorylate adducin (Kimura, Fukata 
et al. 1998; Fukata, Oshiro et al. 1999), which, together with spectrin, is an important 
component of the cortical actin network underlying the plasma membrane (Gardner and 
Bennett 1987). ROCK-phosphorylated adducin interacts with filamentous-actin (F-actin), 
and its localization suggests a role in regulating cellular migration. In HGF/SF-stimulated 
MDCK cells, phosphoadducin localizes to membrane ruffles, and ROCK-phosphorylated 
adducin localizes to the leading edge of migrating NRK49F fibroblasts in wound healing 
assays (Fukata, Oshiro et al. 1999); while the introduction of nonphosphorylatable 
adducin into MDCK and NRK49F cells inhibited membrane ruffling and migration, as did 
a dominant negative ROCK mutant (Fukata, Oshiro et al. 1999). ROCK can also 
phosphorylate the ERM proteins that are important for linking actin filaments to the 
plasma membrane (Matsui, Maeda et al. 1998). Interestingly, it has been demonstrated 
that the TSC1 tumor suppressor hamartin regulates cell adhesion to cell substrates 
through the ERM family of actin-binding proteins and RhoA (Lamb, Roy et al. 2000). 
Finally, NHE1 is well known as a ubiquitous Na+/H+ exchange protein that enables stress 
fiber formation (Tominaga, Ishizaki et al. 1998). 
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3.2.3 Rac and Cdc42 signaling 
In classical Swiss 3T3 fibroblast model, activation of Cdc42 leads to filopodia formation, Rac 
results in lamellipodia formation and membrane ruffling, and Rho results in stress fibers 
formation (Nobes and Hall 1995). The cytoskeletal rearrangements caused by Rho GTPases 
activation play a key role in cell motility. In addition to their effects on the actin cytoskeleton 
and motility, Rac and Cdc42 also play a role in cell-cell adhesion in epithelial cells. 
Expression of a constitutively active form of Rac in MDCK cells or keratinocytes leads to an 
increase in E-cadherin complex members and F-actin at cell-cell contacts, while a dominant 
negative mutant was found to disrupt cell-cell adhesions (Braga, Machesky et al. 1997; 
Takaishi, Sasaki et al. 1997; Jou and Nelson 1998). A number of studies have suggested that 
Cdc42 plays an important role in establishing the initial polarization of epithelial cells, 
which is required for the proper formation of cell-cell adhesions. For example, transfection 
of a dominant negative form of Cdc42 in MDCK cells results in the selective depolarization 
of basolateral membrane proteins due to inhibition of membrane transport (Kroschewski, 
Hall et al. 1999). Expression of a constitutively active form of Cdc42 in MDCK cells 
increased AJs and blocked cellular migration induced by HGF/SF (Kodama, Takaishi et al. 
1999). 
Given the importance of Rac and Cdc42 in the regulation of cell cytoskeletal, adhesion and 
motility, it has been widely considered that they play important roles in cellular processes 
related to invasion and metastasis. The first evidence of Rac’s role in invasion was obtained 
when Rac-specific GEF T-lymphoma invasion and metastasis (Tiam-1) was identified in a 
retroviral insertional mutagenesis screen. Virus-infected T-lymphoma cells were repeatedly 
selected for in vitro invasion through a layer of fibroblasts and the proviral insertions in 
invasive clones were used to identify the Tiam-1 gene (Habets, Scholtes et al. 1994). 
Subsequently, Rac, and later Cdc42, were shown to also confer an invasive potential to these 
T-lymphoma cells (Michiels, Habets et al. 1995; Stam, Michiels et al. 1998). More evidence 
for Rac and Cdc42’s involvement in invasion and metastasis has been provided since then. 
Expression of the laminin-receptor ǂ6ǃ4 integrin in the melanoma cell line MDA-MB-435 
promotes invasiveness in a Rac and PI3-kinase-dependent manner (Shaw, Rabinovitz et al. 
1997). In addition, constitutively active forms of Rac and Cdc42 in breast carcinoma cell line 
T47D promote invasion through a collagen matrix. However, this invasion can be blocked 
by PI3-Kinase inhibitors, indicating that PI3-kinase acts downstream of Rac and Cdc42 
(Keely, Westwick et al. 1997). 
3.2.4 Effectors of Rac and Cdc42 
A number of Rac and Cdc42 effectors have been identified. Some of these have been found 
to specifically mediate cell motility, whereas others play a more prominent role in mediating 
cell adhesion. It is well established that WASP and MRCKs are Cdc42 specific effectors that 
regulate actin organization and filopodia formation which promotes a more motile 
phenotype (Aspenstrom, Lindberg et al. 1996; Miki, Miura et al. 1996). In addition, members 
of the p21-activated kinase family (PAK), downstream of Rac and Cdc42, play important 
roles in cytoskeletal-mediated changes that affect motility (Manser, Leung et al. 1994). The 
scalffold proteins IQGAP and Par-6, both of which can be activated by Cdc42 and rac, 
promote cell polarization and contribute to cell-cell adhesion. 
The scaffold protein N-WASP binds to Arp2/3 complexes that are crucial for the assembly 
of within filopodia (Kolluri, Tolias et al. 1996). It has been shown that both N-WASP and 
Arp2/3 complexes are required for Cdc42 to trigger actin filament assembly (Welch, DePace 
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et al. 1997; Miki, Sasaki et al. 1998). Therefore, N-WASP may promote cellular motility 
through proper filopodia formation. MRCKs ǂ and ǃ are Cdc42 specific effectors that can 
phosphorylate MLC via a ROCK-like kinase domain (Leung, Chen et al. 1998). It is well 
accepted that phosphorylation of MLC is required for actomyosin complex assembly and 
contraction. Overexpression of MRCKǂ and Cdc42 synergizes to promote filopodia 
formation, while a MRCKǂ kinase-deficient mutant inhibits the formation of Cdc42-induced 
filopodia (Leung, Chen et al. 1998). Therefore, MRCDs are believed to play important roles 
in cytoskeletal organization and contraction, and contribute to migration. PAK, a protein 
kinase downstream of Rac and Cdc42, plays a crucial role in actin dynamics and adhesion 
(Manser, Leung et al. 1994). PAK has been demonstrated to phosphorylate and inactivate 
MLCK, subsequently causing a decrease in MLC phosphorylation (Sanders, Matsumura et 
al. 1999). Thus, inactivation of MLCK leads to stress fiber and focal adhesion disassembly. 
Moreover, PAK controls the actin cytoskeletion through the phosphorylation and 
subsequent activation of LIM-kinase. Phosphor-LIM-kinsae can further phosphorylate and 
inactivate the actin-depolymerizing protein cofilin, thus inhibiting actin depolymerization 
when Rac is activated and causing extreme membrane ruffling (Arber, Barbayannis et al. 
1998; Yang, Higuchi et al. 1998). The IQGAP1 and IQGAP2 scaffolding effectors of Cdc42 
and Rac regulate cell-cell adhesion through actin polymerization and sequestration of ǃ-
catenin (Kuroda, Fukata et al. 1996; Erickson, Cerione et al. 1997). In vitro, IQGAP 
oligomerizes and cross-links F-catin it has also been found to complex with Cdc42 and F-
actin in vivo (Fukata, Kuroda et al. 1997). In addition, one study has shown that the IQGAP 
protein also competes with ǂ-catenin for binding to ǃ-catenin, thus preventing E-
cadherin/ǂ-catenin/ǃ-catenin complex from attaching to the actin cytoskeleton, and thereby 
disrupting cell-cell contacts (Erickson, Cerione et al. 1997). Another scaffolding protein, Par-
6, was identified using activated Cdc42 and TC10 mutants as baits in yeast two-hybrid 
screens (Joberty, Petersen et al. 2000; Qiu, Abo et al. 2000). It is known that Par-6 binds to a 
second scaffolding protein, Par-3, and both Par-6 and Par-3 bind independently to atypical 
protein kinase C (aPKC) isioforms (Lin, Edwards et al. 2000). In addition, endogenous Par-3 
localizes to TJs in MDCK cells, overexpression of Par-6 or the N-terminal portion of Par-3 
(the Par-6-interaction responsible region) disrupts TJ formation (Joberty, Petersen et al. 
2000). 
4. Expression of Rho GTPases in breast tumors 
Aberrant Rho signalling resulting from alterations in Rho GTPase protein level, changes in 
activation status, and abnormal quantity of effector proteins are found in a large variety of 
human tumors. of GTPases: the Rho family (RhoA, RhoB and RhoC), the Rac family (Rac1, 
Rac2 and Rac3) and the Cdc42 family, in order to avoid repetitions. 
4.1 Rho GTPases in breast tumors 
Overexpression of RhoC has been found in inflammatory breast cancer (IBC), an aggressive 
form of breast cancer that is highly infiltrative and metastatic with poor prognosis for the 
patients, using in situ hybridization (van Golen, Davies et al. 1999). Compared to normal 
untransformed parental cells, RhoC-transformed cells produce and secrete high levels of 
proangiogenic factors such as vascular endothelial growth factor (VEGF), basic fibroblast 
growth factor (bFGF), interleukin-6 (IL-6), and interleukin-8 (IL-8). when compared to 
normal untransformed parental cells (van Golen, Wu et al. 2000). In addition, microarray 
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analysis has shown that MCF10A breast cells stably transfected with wild type RhoC or a 
constitutively active mutant of RhoC overexpress genes associated with invasion and 
metastasis (Wu, Wu et al. 2004). Other RhoGTPases are also involved in breast tumors. 
RhoA is found overexpressed in breast tumor tissues but not in the normal tissue (Fritz, 
Brachetti et al. 2002). The expression of dominant negative RhoA in rat mammary 
adenocarcinoma cells affects tumor cell growth in vivo and reduces intravasation into the 
peripheral blood, resulting in decrease in lung colonization ability (Fritz, Just et al. 1999). 
Other studies have indirectly shown an important role of RhoA in breast carcinogenesis. For 
example, highly metastatic MDA-MB-231 cells that were treated with HMG-CoA reductase 
inhibitor, namely cerivastain, showed reduced proliferation and invasion through Matrigel, 
in a RhoA- but not Ras-dependent manner (Denoyelle, Vasse et al. 2001). However, poorly 
metastatic breast cancer cells such as MCF-7 are less sensitive to cerivastain treatment, 
indicating that RhoA might be more significantly overexpressed in late stages of breast 
cancer as with other tumors. 
Rho proteins are also important players in breast tumor progression and metastasis exerted 
by the CD44 hyaluronan receptor (Bourguignon 2001). CD44 is expressed in human breast 
tumors and promotes cell growth and metastasis in tumor cells. Studies have found that 
RhoA and CD44 directly interact with each other in vivo in highly metastatic human breast 
cancer cell lines. Accordingly, inhibition of Rho signaling results in the abrogation of the 
metastatic phenotype elicited by CD44 (Bourguignon, Zhu et al. 1999). RhoA has also been 
found to be involved in insulin signaling via Shc in human breast cancer (Finlayson, 
Chappell et al. 2003). Overexpression of insulin receptors correlates with development, 
progression and outcome of breast cancer, and insulin signaling involves 
hyperphosphorylation of Shc. Hence, Shc leads to the activation of geranyl transferases, 
which results in an increased amount of prenylated RhoA in the tumor tissue compared 
with normal mammary tissue (Finlayson, Chappell et al. 2003). Furthermore, RhoA has been 
reported to increase the metastatic potential of tumor cells via its ability to promote tumor 
angiogenesis through the downregulation of thrombospodin-1 (Tsp-1) (Watnick, Cheng et 
al. 2003). Rho pathway is part of the downstream signaling cascade that is activated by PI3K 
and leads to ROCK stimulation, Myc phosphorylation and Tsp-1 repression. 
4.2 Rac GTPases in breast tumors 
The involvement of Rac GTPases in breast cancer was first reported in rodents (Bouzahzah, 
Albanese et al. 2001). Expression of a dominant negative Rac1 mutant indicated that Rac1 
affects tumor cell growth and metastasis in vivo. Deregulation of Rac3, closely related to 
Rac1, has also been detected in breast cancer (Mira, Benard et al. 2000). Rac3 maps to 
chromosome band 17q25.3, a region known to contain candidate tumor suppressor genes 
both in breast and ovarian cancers (Morris, Haataja et al. 2000). Highly proliferative breast 
cancer cells, T47D and MCF-7, but not normal breast cell lines, contain constitutively active 
Rac3 in a Ras-independent manner (Morris, Haataja et al. 2000). It has also been shown that 
expression of a dominant negative mutant Rac3 (N17) leads to inhibition of S-phase entry 
and cellular proliferation in breast tumor cells, which indicate that Rac3 may promote cell 
growth (Leung, Nagy et al. 2003). Further, the Rac-PAK signaling pathway is essential for 
receptor tyrosine kinase ErbB2-mediated transformation of human breast epithelial cancer 
cells (Mazieres, Antonia et al. 2004). Activation of Rac-PAK1 pathway by ErbB2 
homodimers can induce growth factor-independent proliferation and promote disruptions 
to the three-dimensional (3D) mammary acinar-like structures, via activation of the Erk and 
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Akt pathways (Mazieres, Antonia et al. 2004). Moreover, Rac1 enhances estrogen receptor ǂ 
(ERǂ) transcriptional activity, resulting in increased proliferation in breast cancer cells 
(Rosenblatt, Garcia et al. ; Folkman 1972).  
4.3 Cdc42 family in breast tumors 
Cdc42 is overexpressed in some breast cancers and there is accumulating evidence that 
activated Cdc42 contributes to the accumulation of ErbB1 in cells through the regulation 
of c-Cbl function (Abraham, Kuriakose et al. 2001; Marionnet, Lalou et al. 2003). The view 
that Cdc42 is involved in human breast carcinogenesis is supported by a rodents model of 
breast carcinoma where the expression of a dominant negative mutant of Cdc42 reduced 
the number of focal contacts, inhibited colony formation in soft agar and affected cell 
growth in vivo (Fritz, Just et al. 1999). The dominant negative Cdc42 also reduced 
intravasation of tumor cells into peripheral blood and ability to form lung metastasis. In 
addition, through the activation of Cdc42, transforming growth factor ǂ (TGF-ǂ) mediates 
the invasion of MDA-MB-231 cells into 3-D collagen matrices by initiating the formation 
of protrusions into collagen. (Kamai, Tsujii et al. 2003; Fisher, Sacharidou et al. 2009). 
Further, another study has shown that membrane-type-1 matrix metalloproteinase (MT1-
MMP) and Cdc42 are fundamental components of a co-associated invasion-signaling 
complex that controls directed single-cell invasion of 3D collagen matrices (Fisher, 
Sacharidou et al. 2009). 
5. Multiple functions mediated by Rho GTPases in breast cancer 
Rho GTPases mediate housekeeping aspects of cell biology including cell growth, cell 
polarity, cell adhesion, membrane trafficking and motility. They function as signaling 
switches that regulate lipid metabolism, microtubules- and actin-based structures, epithelial 
cell-junctions, cell cycle and apoptosis regulatory proteins, and transcription factors. 
5.1 Rho GTPases and cytoskeleton organization 
Eukaryotic cellular morphology and attachment to the substratum in response to 
extracellular signals are largely dependent on rearrangements of the actin cytoskeleton. Cell 
motility, cytokinesis and phagocytosis all rely on coordinated regulation of the actin 
cytoskeleton (Small 1994; Zigmond 1996). Filamentous actin can be organized into several 
discrete structures: (a) filopodia, finger-like protrusions that contain a tight bundle of long 
actin filaments in the direction of the protrusion. These are found primarily in motile cells 
and neuronal growth cones. (b) lamellipodia, thin protrusive actin sheets that dominate the 
edges of cultured fibroblasts and many other motile cells. Membrane ruffles observed at the 
leading edge of the cell result from lamellipodia that lift up off the substrate and fold 
backward. (c) actin stress fibers, bundles of actin filaments that traverse the cell and are 
linked to the ECM through focal adhesion (Van Aelst and D'Souza-Schorey 1997). The actin 
polymerization is tightly regulated by Rho GTPases. 
Rho activation in fibroblasts is known to stimulate the assembly of contractile actin/myosin 
filaments, the formation of stress fibers, and the clustering of integrins involved in the 
formation of focal adhesion complexes. Activation of Rac facilitates actin polymerization at 
the cell periphery to generate protrusive actin-rich lamellipodia and membrane ruffling. 
And activation of Cdc42 results in actin polymerization to form peripheral actin microspikes 
and filopidia. As described previously, a number of proteins have been identified as targets 
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of Rho, Rac and Cdc42 (Fig. 3). Most of them are involved in Rho GTPases mediated 
cytoskeletal rearrangements (Tang, Olufemi et al. 2008). 
 
 
Fig. 3. A model of the cellular migratory process. See text for detailed explanation of motility 
phases. 
5.2 Rho GTPases in cell migration 
Cell migration is a multistep process involving polarization, sequential cell protrusion and 
adhesion formation in the direction of migration, cells body contraction, and tail detachment 
(Pinner and Sahai 2008). During the migration process, cells move with extending 
protrusions at the front and a retracting tail at the rear, both regulated by members of the 
Rho GTPases family (Ridley, Schwartz et al. 2003). The idea that Rho family GTPases could 
regulate cell migration derives from observations that they mediate the formation of specific 
actin containing structures. In addition, Rho proteins regulate several other processes that 
are relevant to cell migration, including cell-substrate adhesion, cell-cell adhesion, protein 
secretion, vesicle trafficking, and transcription. 
5.2.1 Cell polarization and lamellipodium extension at the leading edge 
An asymmetrical organization of intracellular activities is required for a cell to move, that 
means the molecular processes at the leading and trailing edges of a moving cell must be 
different. Establishing and maintaining cell polarity in response to extracellular stimuli 
appear to be mediated by Rho family GTPases. 
Cdc42 is well accepted as a master regulator of cell polarity in eukaryotic organisms ranging 
from yeast to human.Cdc42 was first studied in a budding yeast model for its involvement 
in cell polarity. During the cell cycle, yeast cells adopt alternative states of growth to non-
focused isotropic growth. In the absence of Cdc42, Saccharomyces cerevisiae fail to establish 
focused apical growth and, cells expand isotropically (Pruyne and Bretscher 2000). Cdc42 
regulates cell polarity by deciding the location of lamellipodia formation (Srinivasan, Wang 
et al. 2003). In addition, Cdc42 directs the localization of the microtubule-organizing center 
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(MTOC) and Golgi apparatus to the front of the nucleus, oriented toward the direction of 
movement. MTOC orientation at the leading edge then facilitates the delivery of Golgi 
derived vesicles to the leading edge and microtubule growth into the lamellipodium 
(Rodriguez, Schaefer et al. 2003). It has been further studied that Cdc42 exerts its effect on 
MTOC through its downstream effector, PAK1 (Li, Hannigan et al. 2003).  
5.2.2 Protrusion formation 
Inherent polarity drives the formation of membrane protrusions, and the organization of 
filaments depends on the type of protrusion. Actin filaments form a branching dendritic 
network in lamellipodia, but form long parallel bundles in filopodia (Pollard, Blanchoin et 
al. 2000). The dendritic organization of lamelipodia that provides a tight brush-like 
structure, formed via the actin-nucleating activity of the actin-related proteins 2/3 (Arp2/3) 
protein complex (Urban, Jacob et al.). Rac stimulates new actin polymerization by acting on 
Arp2/3 complexes, which binds to pre-existing filaments (Campellone and Welch). 
Activation of Arp2/3 complexes by Rac is carried out through its target IRSp53. Upon 
activation, IRSp53 interacts with WAVE through its SH3 domain, it then binds to and 
activates Arp2/3 complexes (Chesarone and Goode 2009). It has also been reported that 
IRSp53 binds to Cdc42 through a separate domain (Miki, Yamaguchi et al. 2000). So, IRSp53 
can serve as a direct link between Cdc42 and Rac, which explains how Cdc42 induces Rac 
involvement in lamellipodium formation. Furthermore, IRSp53 can bind to a Rho target, 
Dial, which might underlie the capability of Rho to facilitate lamellipodium extension (Cox 
and Huttenlocher 1998; Fujiwara, Mammoto et al. 2000). 
5.2.3 Cell-substrate adhesions 
Newly formed focal adhesion complexes are localized in the lamellipodia of most migrating 
cells. Once the lamellipodium attach to the ECM, integrins come into contact with ECM 
ligands and cluster in the cell membrane where they interact with FAK, ǂ-actin, and talin 
(Cox and Huttenlocher 1998). All these proteins can bind to adaptor proteins through Src-
homologous domain 2 and 3 (SH2, SH3) as well as proline rich domains to more actin 
binding proteins (vinculin, paxillin and ǂ-actin) and regulatory molecules PI3K to focal 
complexes (Zamir and Geiger 2001). Rac is required for focal complex assembly, and Rac 
itself can be activated by cell-substrate ECM adhesion (Rottner, Hall et al. 1999). It is 
suggested that the adhesion assemblies in migrating cells begin with small-scale clustering 
and the speed of the cell migration is dependent on ECM composition, which determines 
the relative activated levels of Rho, Rac and Cdc42 (Price, Leng et al. 1998). Therefore, 
interactions between ECM and integrins at the leading edge of cells play an important role 
in maintaining the level of active Rac. This indicates the existence of a positive feedback 
loop that allows continuous crosstalk between integrins and Rac, and allows cells to respond 
to changing ECM composition. 
5.2.4 Cell body contraction by actomyosin complexes 
Cell body contraction is driven by actomyosin contractility and the force transmitted to sites 
of adhesion derives from myosin II. Myosin II, which is predominantly induced by Rho and 
its downstream effector ROCK, controls stress fiber assembly and contraction. Rho acts via 
ROCKs to affect MLC phosphorylation by inhibiting MLC phosphatase or the MLC 
phosphorylation. MLC phosphorylation is also regulated by MLCK, which is controlled by 
both intracellular calcium concentration and ERK MAPKs (Fukata, Amano et al. 2001). 
www.intechopen.com
 
Rho GTPases and Breast Cancer 571 
ROCKs and MLCK have been suggested to act in concert to regulate different aspects of cell 
contractility, since ROCK appears to be required for MLC phosphorylation which are 
associated with actin filaments in the cell body, and MLCK is required at the cell periphery 
(Totsukawa, Yamakita et al. 2000).  
5.2.5 Adhesion disassembly and tail detachment 
Tail detachment occurs when cell-substrate linkages are preferentially disrupted at the rear 
of a migrating cell, while the leading edge remains attached to the ECM and continues to 
elongate (Palecek, Huttenlocher et al. 1998). Mechanisms underlying the focal complex 
disassembly and tail detachment depend on the type of cell and strength of adhesion to the 
extracellular matrix at the trailing edge (Wear, Schafer et al. 2000). In slow moving cells, tail 
detachment depend on the action of a calcium-dependent, non-lysosomal cysteine protease 
calpain that cleaves focal complex components like talin and cytoplasmic tail of ǃ1 and ǃ3 
integrins along the trailing edge (Potter, Tirnauer et al. 1998). Strong tension forces exerted 
across the cells at the rear adhesions is required to break the physical link between integrin 
and the actin cytoskeleton. Rho and myosin II are involved in this event. Furthermore, Rho 
plays important roles in reducing adhesion and promoting tail detachment in fibroblasts, 
which have relatively large focal adhesion complexes (Cox and Huttenlocher 1998). 
5.3 Rho GTPases and transcriptional activation 
A number of studies have suggested that Rho family GTPases are involved in the regulation 
of nuclear signaling. Rac and Cdc42, but not Rho, have been demonstrated to regulate the 
activation of JNK and reactivate kinase p38RK in certain cell types (Seger and Krebs 1995). 
Expression of constitutively active forms of Rac and Cdc42 in HeLa, NIH-3T3, and Cos cells 
stimulates JNK and p38 activity (Coso, Chiariello et al. 1995). Furthermore, these same 
effects were observed with oncogenic GEFs for these Rho proteins (Minden, Lin et al. 1995). 
However in human kidney 293 T cells, Cdc42 and the Rho protein, but not Rac, induces the 
activation of JNK (Teramoto, Crespo et al. 1996). Upon activation, JNKs and p38 translocate 
to the nucleus where they phosphorylate transcription factors, including c-Jun, ATF2, and 
Elk (Derijard, Hibi et al. 1994; Gille, Strahl et al. 1995). Further, Rac has been shown to 
activate PEA3, a member of the Ets family, in a JNK-dependent manner (O'Hagan, Tozer et 
al. 1996). Activated p38 phosphorylates ATF2, Elk, Max, and the cAMP response element 
binding protein. 
PAKs are the farthest known upstream kinases that connect Rho GTPases to JNK and p38 
through GTP-dependent bindings to Rac and Cdc42 in vitro and are activated after binding 
to activated Rac and Cdc42. (Manser, Chong et al. 1995). In addition, certain constitutively 
active forms of PAK can activate JNK and p38 (Zhang, Han et al. 1995). Further, a mutant 
effector of Rac that cannot bind to PAK remains a potent JNK activator (Westwick, Lambert 
et al. 1997). These observations suggest that other kinases, in addition to PAK, participate in 
the signalling from Rho GTPases to JNK. Supporting this, MLK3 and MEKK4 are found to 
be regulated by Cdc42 and Rac, and selectively activate the JNK pathway (Gerwins, Blank et 
al. 1997). It has also been reported that Cdc42/Rac can bind to MLK3 both in vitro and in vivo 
and that the coexpression of activated Cdc42/Rac mutants elevates the enzymatic activity of 
MLK3 in Cos-7 cells (Teramoto, Coso et al. 1996; Gerwins, Blank et al. 1997). In addition, 
Rho, Rac and Cdc42 stimulate the activation of the serum responsive factor (SRF) (Hill, 
Wynne et al. 1995). SRF forms a complex with TCF/Elk proteins to stimulate transcription 
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with serum response elements (SREs) at their promoter enhancer regions, for example the 
Fos promoter (Treisman 1990). 
5.4 Rho GTPases and cell growth control 
Several lines of evidence have suggested that Rho family members play important roles in 
several aspects of cell growth. The Rho proteins have been shown to increase expression of 
cyclin D1, a cell cycle regulator that controls the transition from G1 phase to S phase, in 
Swiss 3T3 fibroblasts (Yamamoto, Marui et al. 1993; Olson, Ashworth et al. 1995) and in 
mammary epithelial cells (Liberto, Cobrinik et al. 2002). Overexpression of RhoE inhibits cell 
cycle progression by inhibiting translation of cyclin D1 mRNA (Villalonga, Guasch et al. 
2004). In fibroblasts, RhoA is involved in ERK activation and subsequent cyclin D1 
expression (Roovers and Assoian 2003). RhoA also downregulates cdk inhibitors p21 and 
p27 during the G1 phase of the cell cycle (Weber, Hu et al. 1997). Rac 1 is capable of 
regulating the cell cyle through the activation of a number of distinct intra-cellular 
pathways, including the NFκB pathway. In contrast to other Rho proteins, Rac1 can directly 
activate cyclin D1 expression (Page, Li et al. 1999). 
Furthermore, Rho, Rac, and Cdc42 have been demonstrated to possess transforming and 
oncogenic potential in some cell lines. For example, cells with constitutively active forms of 
Rac and Rho display enhanced anchorage independent growth ability, and initiate tumor 
formation when inoculated into nude mice (Khosravi-Far, Solski et al. 1995). The 
observation that Tiam, a Rac GEF, can transform NIH-3T3 cells suggests a role for Rac in 
transformation (van Leeuwen, van der Kammen et al. 1995). While expression of 
constitutively activated Rac is sufficient to cause malignant transformation of rodent 
fibroblasts (Qiu, Chen et al. 1995), this is not the case with Rho (Qiu, Chen et al. 1995), 
suggesting that the growth-promoting effects of the Rho GTPases are specific to cell type. 
Evidence of Cdc42’s role in cell growth has been provided in fibroblasts. The constitutively 
active mutant of Cdc42 stimulates anchorage independent growth and proliferation in nude 
mice (Qiu, Abo et al. 1997). Using a Cdc42 mutant, Cdc42(F28L), that can undergo GTP-GDP 
exchange in the absence of GEF, one study demonstrated that cells stably tranfected with 
Cdc42(F28L) exhibited not only anchorage-independent growth but also lower dependence 
on serum for growth (Lin, Bagrodia et al. 1997). A role for Cdc42 in Ras transformation has 
also been established in Rat 1 fibroblasts. Coexpression of a dominant negative form of 
Cdc42, Cdc42N17, with oncogenic Ras results in inhibition of RasV12-induced focus 
formation and anchorage-independent growth, and reversed the change in morphology in 
RasV12-transformed cells (Qiu, Abo et al. 1997).  
5.5 Rho GTPases and angiogenesis 
Beside their roles in multiple processes of cellular control, tumor growth, progression and 
metastasis, the Rho proteins have also been shown to be involved in angiogenesis, a process 
Where new blood vessels arise from existing mature vessels. This process is controlled by a 
number of pro-angiogenic and anti-angiogenic factors at different stages (Folkman 1972). 
The major pro-angiogenic factors are comprised of vascular endothelial growth factor 
(VEGF), fibroblast growth factors (FGF), platelet derived growth factor-ǃ (PDGFǃ), 
angiopoietins 1 and 2 (Ang-1 and 2), tumor necrosis factor (TNF), interleukin 6 and 8 (IL-6 
and 8), and epidermal growth factor (EGF). The main anti-angiogenic foctors include the 
thrombospondins (TSPs), angiostatin, and endostain (Merajver and Usmani 2005). The Rho 
www.intechopen.com
 
Rho GTPases and Breast Cancer 573 
proteins are believed to be capable of altering the expression and activity of pro-angiogenic 
and anti-angiogenic factors during angiogenesis. 
5.5.1 Regulation of VEGF and hypoxia inducible factor-1 (HIF1) 
It has been reported that hypoxia increases the expression and activity of Cdc42, Rac1 and 
RhoA in renal cell carcinoma cell lines and a human microvascular endothelial cell line 
(Turcotte, Desrosiers et al. 2003). This study demonstrated that reactive oxygen species 
(ROS) are responsible for the upregulation of Rho proteins and that RhoA is required for 
the accumulation of HIF-1ǂ (Turcotte, Desrosiers et al. 2003), a transcription factor 
induced by hypoxia that plays important roles in the process of angiogenesis by inducing 
the transcription of crucial mediators, including VEGF, PDGFǃ and Ang-2 (Gleadle and 
Ratcliffe 1998). In contrast, Rac1 is shown to be involved in hypoxia-induced PI3K 
activation of HIF-1ǂ through a different mechanism (Hirota and Semenza 2001). Hypoxia-
induced expression of Rac1 also contributes to the upregulation of HIF-1ǂ and, 
subsequently, VEGF in gastric and hepatocellular cancer cells (Xue, Bi et al. 2004). VEGF 
has been reported to increase RhoA activity and localization to the cell membrane, and the 
RhoA /ROCK pathway has been implicated in the VEGF-mediated angiogenesis (van 
Nieuw Amerongen, Koolwijk et al. 2003). In addition, RhoA activation also increases 
tyrosine phosphorylation of the primary VEGF receptor, VEGFR-2 (Gingras, Lamy et al. 
2000).  
Overexpression of RhoC in human mammary epithelial cells (HME) and a highly aggressive 
breast cancer cell line, SUM-149, increases VEGF expression (van Golen, Wu et al. 2000). 
Similar finding were found in the MCF10A cells (Wu, Wu et al. 2004), further suggesting 
that RhoC plays a role in, further suggesting that RhoC plays a role in increasing VEGF in 
mammary neoplasis.  
5.5.2 IL-6 and IL-8 expression 
IL-6 is a multifunctional cytokine that is involved in many different biological process, 
including immunological and inflammatory processes, tumor growth and angiogenesis 
(Hirano, Akira et al. 1990; Mateo, Reichner et al. 1994). IL-8 is another important cytokine 
that acts as a pro-angiogenic factor. Both of these cytokines can be induced by hypoxia 
(Yan, Tritto et al. 1995; Mizukami, Jo et al. 2005) and have been shown to upregulate 
VEGF mRNA expression (Cohen, Nahari et al. 1996). Studies indicate that active Rho 
proteins upregulate the expression of NFκB components in NIH-3T3 cells (Perona, 
Montaner et al. 1997; Montaner, Perona et al. 1998). Consistent with Rho-mediated 
activation of NFκB, HKG-CoA reductase inhibitors had been reported to reduce IL-6 
expression by inhibiting Rho proteins (Ito, Ikeda et al. 2002). Rac1 has been shown to 
mediate the activation of a potential oncogen, STAT3, through NFκB regulated IL-6 
signaling (Faruqi, Gomez et al. 2001). 
IL-8 expression has also been found to be regulated by Rho proteins. In human 
endothelial cells, it has been shown that inhibition of RhoA, Rac1 and Cdc42 decreases 
NFκB activation and, therefore, decreases IL-8 mRNA and IL-8 protein expression 
(Hippenstiel, Soeth et al. 2000; Warny, Keates et al. 2000). In addition, RhoC has been 
shown to increase IL-6 and IL-8 expression in aggressive breast cancer cell lines (Xue, Bi et 
al. 2004). These evidences suggest that different Rho proteins modulate IL-6 and IL-8 
through distinct signaling pathways. 
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5.5.3 FGF activation 
FGF1 and FGF2 are the two earliest characterized members of the FGF family of growth 
factors. FGF is an angiogenic factor that is frequently overexpressed in breast and prostate 
cancers. Rac1 and Cdc42 have been reported to increase FGF1 expression by stimulating the 
FGF1 gene promoter region (Chotani, Touhalisky et al. 2000). One study demonstrated that 
Rac1 activity is required for FGF2-induced activation of Ras/MAPK signaling in human 
breast cell line MCF7 (Liu, Chevet et al. 1999). In addition, medium collected from RhoC 
stably transfected HME and SUM149 cells present higher level of FGF2, in comparison to 
those collected from control transfected HME cells (van Golen, Wu et al. 2000). However, 
how Rho proteins regulate FGF expression remains unclear. 
 
 
Fig. 4. Rho family GTPases are involved in different stages of breast cancer progression: 
dedifferentiation and upregulation of uncontrolled proliferation, angiogenesis, invasion and 
metastasis. 
5.5.4 Repression of Tsp-1 
The anti-angiogenic molecule Tsp-1 is capable of inhibiting metalloproteinase-9 (MMP9) 
from releasing the VEGF sequestered in ECM. The oncoprotein Ras has been reported to 
increase VEGF expression and inhibit Tsp-1 expression. One study showed that the 
inhibitory function of Ras on Tsp-1 via PI3K pathway also involve RhoA and RhoC in 
human embryonic kidney cell lines, human mammary cell lines, and breast cancer cell lines 
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(Watnick, Cheng et al. 2003). And the suppression of Tsp-1 always correlates with 
promotion of angiogenesis. 
6. Conclusion 
It is apparent that individual members of Rho GTPases play specific roles in different 
aspects in breast cancer development (Fig. 4). Aberrant expression and activity of Rho 
proteins contribute to the transformation from normal epithelial phenotype, increases in 
proliferation, the promotion of angiogenesis, elevated motility, and metastasis to distant 
organs. RhoA, RhoC and Rac1 are frequently overexpressed in metastatic breast cancers. 
Manipulating the Rho GTPases’ regulatory proteins and their effectors can induce activation 
of Rho proteins, , leading to aberrant transcription factor activation, including that of NFκB, 
that contribute to invasive phenotypes. All this evidence suggests that Rho GTPases could 
be targets in cancer therapy. Therefore, better knowledge of the the regulation mechanisms 
of Rho GTPases in breast cancer may be critical for a more in-depth understanding of tumor 
biology, facilitating development of novel approaches for cancer treatment.  
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